- Home
- CNTM vs EVAX Comparison
CNTM vs EVAX Comparison
Compare CNTM & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTM
- EVAX
- Stock Information
- Founded
- CNTM 2007
- EVAX 2008
- Country
- CNTM United States
- EVAX Denmark
- Employees
- CNTM N/A
- EVAX N/A
- Industry
- CNTM
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNTM
- EVAX Health Care
- Exchange
- CNTM NYSE
- EVAX Nasdaq
- Market Cap
- CNTM 15.9M
- EVAX 16.3M
- IPO Year
- CNTM N/A
- EVAX 2021
- Fundamental
- Price
- CNTM $0.83
- EVAX $2.53
- Analyst Decision
- CNTM
- EVAX Strong Buy
- Analyst Count
- CNTM 0
- EVAX 3
- Target Price
- CNTM N/A
- EVAX $33.33
- AVG Volume (30 Days)
- CNTM 841.1K
- EVAX 6.8M
- Earning Date
- CNTM 03-04-2025
- EVAX 03-26-2025
- Dividend Yield
- CNTM N/A
- EVAX N/A
- EPS Growth
- CNTM N/A
- EVAX N/A
- EPS
- CNTM N/A
- EVAX N/A
- Revenue
- CNTM $21,787,239.00
- EVAX $3,295,000.00
- Revenue This Year
- CNTM N/A
- EVAX $9,039.73
- Revenue Next Year
- CNTM N/A
- EVAX $1.47
- P/E Ratio
- CNTM N/A
- EVAX N/A
- Revenue Growth
- CNTM 12.87
- EVAX N/A
- 52 Week Low
- CNTM $0.67
- EVAX $2.22
- 52 Week High
- CNTM $12.47
- EVAX $22.05
- Technical
- Relative Strength Index (RSI)
- CNTM N/A
- EVAX 40.91
- Support Level
- CNTM N/A
- EVAX $2.43
- Resistance Level
- CNTM N/A
- EVAX $2.80
- Average True Range (ATR)
- CNTM 0.00
- EVAX 0.31
- MACD
- CNTM 0.00
- EVAX 0.07
- Stochastic Oscillator
- CNTM 0.00
- EVAX 16.94
About CNTM CONNECTM TECHNOLOGY SOLUTIONS INC
ConnectM Technology Solutions Inc is a clean energy technology and solutions provider. The company provides residential and light commercial buildings and all-electric original equipment manufacturers (OEMs) with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling and transportation. The group makes electrification more user-friendly, affordable, precise, and socially meaningful by combining technology, data, artificial intelligence, and contemporary design. In addition to its vertically integrated service network, ConnectM offers customers a comprehensive technology stack that enables them to reduce their fossil fuel consumption, lower their energy bills, and decrease their carbon footprint.
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.